Event date: Thursday, May 5, 2022
Time: 1:00 p.m. to 1:30 p.m. EDT
Zoom webinar (free — registration required)
In February 2022, CADTH announced the creation of a Post-Market Drug Evaluation (PMDE) Program.
The PMDE Program is responsible for establishing and coordinating a network of experts in applied drug research, methodology, and data analysis who can deliver timely evidence in response to policy questions about the post-market safety and effectiveness of drugs approved in Canada. To establish a solid network that is responsive and dynamic, funding will be allocated to network partners through both grants (65%) and contracts (35%).
For an opportunity to ask questions and hear answers about the RFP process for Standing Offer Contractors, plan to attend CADTH’s 30-minute PMDE Program information session. You’ll have the opportunity to:
There is no cost to attend but registration is required. After registering, you will receive a confirmation email with information about how to join the webinar.
Dr. Tarry Ahuja, Director, PMDE Program
Nadine Sulatycky, PMDE Program Lead